| Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic COVIDSurg Collaborative, JC Glasbey, D Nepogodiev, JFF Simoes, ... Colorectal Disease 23 (3), 732-749, 2021 | 66 | 2021 |
| Tumor-primed NK cells: waiting for the green light M Sabry, MW Lowdell Frontiers in Immunology 4, 408, 2013 | 63 | 2013 |
| Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors M Sabry, M Tsirogianni, IA Bakhsh, J North, J Sivakumaran, ... The Journal of Immunology 187 (12), 6227-6234, 2011 | 46 | 2011 |
| Tumor-and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures M Sabry, A Zubiak, SP Hood, P Simmonds, H Arellano-Ballestero, ... PLoS One 14 (6), e0218674, 2019 | 43 | 2019 |
| Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer M Sabry, MW Lowdell Stem Cells Translational Medicine 9 (9), 974-984, 2020 | 20 | 2020 |
| A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome H Arellano-Ballestero, M Sabry, MW Lowdell Cells 12 (4), 633, 2023 | 2 | 2023 |
| NK Cells and Cancer M Sabry, MW Lowdell Natural Killer Cells, 2017 | 2 | 2017 |
| Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis S Haran, K Chindera, M Sabry, N Wilkinson, R Arora, A Zubiak, TE Bartlett, ... Cancers 16 (6), 1186, 2024 | | 2024 |
| In Vivo Generation of Memory-like NK Cells for the Treatment of AML and Myelodysplastic Syndrome; Early Clinical Applications of INKmuneTM KH Orchard, H Ballestero, A Zubiak, C Dalley, DS Richardson, R Torrance, ... Blood 140 (Supplement 1), 4590-4591, 2022 | | 2022 |
| Detection of gene cis-regulatory element perturbations in single-cell transcriptomes GHT Yeo, O Juez, Q Chen, B Banerjee, L Chu, MW Shen, M Sabry, ... PLoS Computational Biology 17 (3), e1008789, 2021 | | 2021 |
| Natural killer cell priming composition MW Lowdell, MS Sabry US Patent App. 15/575,939, 2018 | | 2018 |
| Regulation of NK cell responses by target cell recognition M Sabry, E Cournoyer, M Mashar, MW Lowdell IMMUNOLOGY 143, 100-100, 2014 | | 2014 |
| Human natural killer cell responses to tumour-priming M Sabry UCL (University College London), 2014 | | 2014 |
| The unique profile of tumour-primed natural killer cells shows loss of activating receptor expression and pro-inflammatory cytokine secretion upon activation M Sabry, MW Lowdell IMMUNOLOGY 140, 74-74, 2013 | | 2013 |
| 353 Natural Killer Cell Responses to Tumor Priming M Sabry, MW Lowdell european journal of cancer, S86, 2012 | | 2012 |
